Ginsenoside compound K reduces neuronal damage and improves neuronal synaptic dysfunction by targeting Aβ
Background: Alzheimer’s disease (AD) is the most common neurodegenerative condition worldwide, with amyloid ß (Aβ) fibrils presenting as its main pathological feature. This study investigated whether Ginsenoside Compound K (CK) has activity against Aβ and its mechanism in reducing synaptic damage an...
Main Authors: | Na Li, Qihang Pang, Yanhong Zhang, Jianan Lin, Hui Li, Zhen Li, Yaxin Liu, Xingyu Fang, Yu An, Haonan Bai, Dianyu Li, Zhanhong Cao, Jian Liu, Qing Yang, Shaodan Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1103012/full |
Similar Items
-
Protective effects of ginsenoside CK against oxidative stress-induced neuronal damage, assessed with 1H-NMR-based metabolomics
by: Na Li, et al.
Published: (2022-10-01) -
Emerging Roles of Extracellular Vesicles in Alzheimer’s Disease: Focus on Synaptic Dysfunction and Vesicle–Neuron Interaction
by: Martina Gabrielli, et al.
Published: (2022-12-01) -
Neuroprotective Effects of Ginsenoside-Rg1 Against Depression-Like Behaviors via Suppressing Glial Activation, Synaptic Deficits, and Neuronal Apoptosis in Rats
by: Cuiqin Fan, et al.
Published: (2018-12-01) -
Role of Aβ in Alzheimer’s-related synaptic dysfunction
by: Huiqin Zhang, et al.
Published: (2022-08-01) -
Proteomic analysis reveals that the protective effects of ginsenoside Rb1 are associated with the actin cytoskeleton in β-amyloid-treated neuronal cells
by: Ji Yeon Hwang, et al.
Published: (2016-07-01)